IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.29
+0.01 (+5.22%)
As of Mar 22, 10:54 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +5,364.7% upside
Low Target $13.90
Average Target $15.64
High Target $22.29
Current Price $0.29
Current
$0.29
Target
$15.64
$13.90 $15.64 avg $22.29
Scenario Analysis
Bear Case
$13.90
4,756.7%
Low target
Base Case
$15.64
+5,364.7%
Avg target
Bull Case
$22.29
+7,688.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$0.50
-42.6% from high
52-Week Low
$0.24
+18.3% from low
Target vs 52W High
$15.64
+3,037.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%